子宫内膜异位症MRI检查中围操作期决定是否使用静脉对比剂的可行性
回顾性描述性横断面单中心研究纳入2021年4月至2023年2月因评估子宫内膜异位症接受盆腔MRI的303例连续患者,由经验丰富的放射科医生根据平扫序列所见及有无附加问题围操作期决定是否使用静脉对比剂。219/303(72.3%)患者经平扫序列评估并排除附加问题后决定不使用对比剂,84/303(27.7%)患者使用了对比剂,最常见原因为卵巢病变性质不定(41/84例,48.8%)或怀疑盆腔静脉淤血综合征(26/84例,31.0%)。作者结论认为该决策可行且省力,可使大多数病例避免使用对比剂,需要时使用可避免重复检查。
要点
- 平扫序列评估后可避免对比剂的比例为219/303(72.3%)。
- 使用对比剂最常见原因为卵巢病变性质不定(41/84例,48.8%)。
- 使用对比剂第二常见原因为怀疑盆腔静脉淤血综合征(26/84例,31.0%)。
核心结论
- 子宫内膜异位症MRI中围操作期决定是否使用静脉对比剂可行且省力,可使大多数病例避免使用对比剂,需要时使用可避免重复检查。
研究设计与样本
- 回顾性、描述性横断面单中心研究,纳入2021年4月至2023年2月因评估子宫内膜异位症接受盆腔MRI的303例连续患者(平均年龄33.4岁±8.3)。
关键影像表现/征象
- 由经验丰富的放射科医生根据平扫序列所见及有无附加问题,围操作期决定是否使用静脉对比剂。
- 219/303(72.3%)患者经平扫序列评估并排除附加问题后决定不使用对比剂。
- 84/303(27.7%)患者使用了对比剂,最常见原因为卵巢病变性质不定(41/84例,48.8%)或怀疑盆腔静脉淤血综合征(26/84例,31.0%)。
- 平扫与增强MRI两组患者结局未见相关差异。
临床应用与阅片要点
- 作者认为,根据平扫序列所见及有无附加问题围操作期决定是否使用静脉对比剂是可行的,可使大多数病例避免使用对比剂。
- 作者认为,若判定需要使用对比剂,可避免重复检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the feasibility of a periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis and to evaluate the frequency and reasons of contrast administrations, the corresponding MRI diagnoses, and outcome.
METHODS: In this retrospective, descriptive cross-sectional single-center study all patients were included, who received a pelvic MRI for evaluation of endometriosis between April 2021 and February 2023. Frequency and reasons of optional intravenous administration of contrast media, corresponding MRI diagnoses and clinical outcome data were noted after re-review of all images, review of radiology reports and review of patients' medical records. The decision on the administration of intravenous contrast media had been made by experienced radiologists, depending on the findings of the non-contrast sequences and the presence of ancillary questions.
RESULTS: 303 consecutive patients (mean age, 33.4 years +/- 8.3 [standard deviation]) were evaluated. Periprocedural decision on the administration of intravenous contrast media had been made in all cases. For 219/303 (72.3%) patients, it was decided after review of the non-contrast sequences and exclusion of ancillary questions that contrast administration was not required. 84/303 (27.7%) patients received contrast media, and the most frequent reasons were indeterminate ovarian lesion (41/84 cases, 48.8%) or suspicion of pelvic venous congestion syndrome (26/84 cases, 31.0%). No relevant differences in patient outcomes could be noted (non-contrast/contrast MRI).
CONCLUSIONS: A periprocedural decision on the administration of contrast media in MRI for endometriosis is feasible with little effort. It allows the administration of contrast media to be avoided in most cases. If the administration of contrast media is deemed necessary, repeat examinations can be avoided.
引用
- Harth, Roller, Zeppernick, et al. Feasibility of periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis. Eur J Radiol. 2023. PMID: 37392544. doi:10.1016/j.ejrad.2023.110949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。